Literature DB >> 9522025

Cardioprotective effects of dihydrolipoic acid and tocopherol in right heart hypertrophy during oxidative stress.

T Thürich1, J Bereiter-Hahn, M Schneider, G Zimmer.   

Abstract

Rat hearts hypertrophied by exposure of the animals to low oxygen pressure were perfused by the Langendorff technique. After oxidative stress induced by hypoxia/reoxygenation, functional recovery of the hypertrophied right heart was insufficient when compared to non-hypertrophied controls. Accordingly, mitochondrial membrane potential did not recover sufficiently. There was a positive trend for improvement of the rate-pressure product during reoxygenation in lipoic acid (CAS 1077-28-7; 0.8 mumol/l) treated hearts which was also verified for membrane potential. Adenosine 5'-triphosphate and creatine phosphate contents as well as the ATP/ADP ratio in hypertrophied right ventricle were significantly increased after reoxygenation in hearts treated with lipoic acid. With lipoic acid, there was a significantly higher content of glutathione (oxidized form) after reoxygenation, Ca2+ uptake was significantly increased in mitochondria isolated from hypertrophied right ventricles and treated by 12 nmol/mg protein of lipoic acid. The results reveal a distinct improvement of mitochondrial structure/function by lipoic acid and suggest for therapy a combination with the synergistic free radical scavenging properties of tocopherol (CAS 10191-41-0).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9522025

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  2 in total

1.  Modulation of oxidative stress-induced changes in hypertension and atherosclerosis by antioxidants.

Authors:  Sudesh Vasdev; Vicki D Gill; Pawan K Singal
Journal:  Exp Clin Cardiol       Date:  2006

2.  Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats.

Authors:  Agadihiremath Vishwanatha Swamy; Sumeet Gulliaya; Agadihiremath Thippeswamy; Basavaraj C Koti; Donnahalli V Manjula
Journal:  Indian J Pharmacol       Date:  2012-01       Impact factor: 1.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.